Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Price

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|October 13, 1979
Cancer trialsL A Price, B T Hill
Clinical Oncology|December 1, 1979
Cancer chemotherapyL A Price, B T Hill
Cancer Treatment Reviews|September 1, 1990
Higher average received relative dose intensities of cyclophosphamide, methotrexate and 5-fluorouracil using a 24-hour method: implications for improved cure rates in breast cancerL A Price, B T Hill
British Journal of Haematology|May 1, 1973
Bone-marrow toxicity of methotrexate: a reassessmentI D Douglas, L A Price
Journal of Learning Disabilities|October 27, 2004
At second glance: employers and employees with learning disabilities in the Americans with Disabilities Act eraL A Price, P J Gerber
British Medical Journal (Clinical Research Ed.)|September 24, 1983
Adjuvant chemotherapy for early breast cancerL A Price, B T Hill
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 10, 1983
An experimentally based safe method of administering intensive cancer chemotherapy. Prospects for increased survival in patients with 'solid' tumours during the next decadeL A Price, B T Hill
Clinical Otolaryngology and Allied Sciences|November 1, 1977
A kinetically based logical approach to the chemotherapy of head and neck cancerL A Price, B T Hill
American Journal of Clinical Oncology|February 1, 1994
Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rateB T Hill, L A Price
Cancer Treatment Reviews|June 1, 1980
DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-methylpyrimidine)B T Hill, L A Price
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|October 13, 1979
Cancer trialsL A Price, B T Hill
Clinical Oncology|December 1, 1979
Cancer chemotherapyL A Price, B T Hill
Cancer Treatment Reviews|September 1, 1990
Higher average received relative dose intensities of cyclophosphamide, methotrexate and 5-fluorouracil using a 24-hour method: implications for improved cure rates in breast cancerL A Price, B T Hill
British Journal of Haematology|May 1, 1973
Bone-marrow toxicity of methotrexate: a reassessmentI D Douglas, L A Price
Journal of Learning Disabilities|October 27, 2004
At second glance: employers and employees with learning disabilities in the Americans with Disabilities Act eraL A Price, P J Gerber
British Medical Journal (Clinical Research Ed.)|September 24, 1983
Adjuvant chemotherapy for early breast cancerL A Price, B T Hill
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 10, 1983
An experimentally based safe method of administering intensive cancer chemotherapy. Prospects for increased survival in patients with 'solid' tumours during the next decadeL A Price, B T Hill
Clinical Otolaryngology and Allied Sciences|November 1, 1977
A kinetically based logical approach to the chemotherapy of head and neck cancerL A Price, B T Hill
American Journal of Clinical Oncology|February 1, 1994
Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rateB T Hill, L A Price
Cancer Treatment Reviews|June 1, 1980
DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-methylpyrimidine)B T Hill, L A Price
Pageof 11